This doesn't mean that it won't happen, but it does make it especially vile if it does.
If people take GLP-1 meds and get down into the normal range, at that point even if they stay on the drugs, they're going to have to adjust the dose so they stop losing weight again (without gaining weight).
This means that even if everyone who's overweight or obese started taking GLP-1 drugs and started losing weight right now, the reduction in food consumption would still be limited and short term.
So I think this concern is somewhat overblown.
So its not out of the question that processed food and alcohol companies might lobby to restrict or ban these medications to protect their profits, despite them being proven to be medically effective.
It wouldn't be the first time corporate profit interests override the interests of ordinary people.
ggm•1mo ago
Cost, and price are of course fully disconnected here. I look forward to Indian and Canadian generics in due course.
toomuchtodo•1mo ago
Lilly is building a large manufacturing facility north of Indianapolis in Lebanon, and these drugs will be part of their manufacturing.
devilbunny•1mo ago
Vastly. Dehydrating purified compounds is cheap and easy, and pills don't have to be truly sterile. Sterile injectables are not cheap lines to set up even aside from packaging in the injector.
iancmceachern•1mo ago
hyghjiyhu•1mo ago
cheald•1mo ago